neoplasia

(redirected from Cin)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

ne·o·pla·sia

 (nē′ō-plā′zhə)
n.
1. Formation of new tissue.
2. Formation of a neoplasm or neoplasms.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

neoplasia

(ˌniːəˈpleɪzɪə)
n
(Medicine) an abnormal growth of tissue, the development of a neoplasm, or the process that results in the production of a neoplasm or tumour
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ne•o•pla•sia

(ˌni oʊˈpleɪ ʒə, -ʒi ə, -zi ə)

n.
the formation and growth of neoplasms.
[1885–90]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.

neoplasia

the abnormal proliferation of benign or malignant cells. — neoplastic, adj.
See also: Cancer
the growth or formation of a neoplasm. — neoplastic, adj.
See also: Growth
the growth or formation of aneoplasm. — neoplastic, adj.
See also: Body, Human
-Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neoplasia - the pathological process that results in the formation and growth of a tumor
pathologic process, pathological process - an organic process occurring as a consequence of disease
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ne·o·pla·si·a

n. neoplasia, formación de neoplasmas.
English-Spanish Medical Dictionary © Farlex 2012

neoplasia

n neoplasia (proceso)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
In March 2017, the CIN journalists requested from this hospital the data on donations received in the period from 2010.
The individual risk for acquiring CIN depends on numerous exogenous and endogenous circumstances such as the type and volume of CM used, the type of diagnostic or therapeutic procedure applied, and specific comorbidities [5].
The discrimination between low- and high-grade CIN cases is very important since low-grade cases are treated differently than high-grade cases.
Various laboratory parameters and scoring systems have shown to be successful at predicting the development of CIN [10].
On histopathology, 144 (65.45%) were benign showing chronic cervicitis, whereas 52 (23.64%) and 24 (10.9%) cases were diagnosed as CIN 1 (LGL) and HGL (CIN 2, CIN 3) respectively (Table 2).
Pipeline Products for Cervical Intraepithelial Neoplasia (CIN) - Overview 7
Based on the different test results, patients were categorized as low or potential risk for developing CIN. The results of the POC measurements were used to determine if contrast administration was regarded as safe at this moment.
There is accumulating evidence that CIN is caused by a combination of a reduction in medullary blood flow resulting in hypoxia and direct tubular damage, including apoptosis [6-8].
Both coronary angiography and PCI needs contrast medium for procedure, and contrast medium is a common precipitator of CIN.11
Several studies have demonstrated a potential for select antioxidants in the treatment of CIN, including vitamin C, vitamin A, beta-carotene, and selenium.
The report provides comprehensive information on the therapeutics under development for Cervical Intraepithelial Neoplasia (CIN), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.